Index S&P 500 P/E 26.00 EPS (ttm) 9.21 Insider Own 2.03% Shs Outstand 51.34M Perf Week 4.06%
Market Cap 12.29B Forward P/E 19.24 EPS next Y 12.44 Insider Trans -3.04% Shs Float 50.31M Perf Month -9.86%
Income 474.62M PEG 2.83 EPS next Q 2.06 Inst Own 101.29% Short Float 3.15% Perf Quarter 12.35%
Sales 4.13B P/S 2.98 EPS this Y 3.35% Inst Trans 3.21% Short Ratio 2.97 Perf Half Y 32.10%
Book/sh 70.06 P/B 3.42 EPS next Y 12.83% ROA 6.01% Short Interest 1.58M Perf Year 17.47%
Cash/sh 5.50 P/C 43.51 EPS next 5Y 9.19% ROE 14.44% 52W Range 161.65 - 275.00 Perf YTD 1.28%
Dividend Est. - P/FCF 33.65 EPS past 5Y 14.84% ROI 7.12% 52W High -12.93% Beta 1.43
Dividend TTM - Quick Ratio 1.16 Sales past 5Y 12.89% Gross Margin 33.56% 52W Low 48.12% ATR (14) 7.08
Dividend Ex-Date - Current Ratio 1.52 EPS Y/Y TTM -3.17% Oper. Margin 15.82% RSI (14) 43.31 Volatility 3.11% 2.55%
Employees 21800 Debt/Eq 0.87 Sales Y/Y TTM 3.86% Profit Margin 11.49% Recom 1.94 Target Price 271.56
Option/Short Yes / Yes LT Debt/Eq 0.85 EPS Q/Q -0.65% Payout 0.00% Rel Volume 1.32 Prev Close 240.13
Sales Surprise 2.24% EPS Surprise 2.42% Sales Q/Q -7.85% Earnings May 09 BMO Avg Volume 533.03K Price 239.43
SMA20 -3.69% SMA50 -5.31% SMA200 10.78% Trades
Volume 705,117 Change -0.29%
Date
Action
Analyst
Rating Change
Price Target Change
Feb-15-24 Downgrade Guggenheim
Buy → Neutral
Sep-13-23 Initiated TD Cowen
Market Perform
$212
Jul-10-23 Downgrade Citigroup
Buy → Neutral
$260 → $225
Feb-23-23 Upgrade Guggenheim
Neutral → Buy
$255
Jan-12-23 Downgrade Jefferies
Buy → Hold
Sep-30-22 Upgrade Jefferies
Hold → Buy
$240
Aug-25-22 Initiated Credit Suisse
Outperform
$285
Aug-04-22 Downgrade Morgan Stanley
Overweight → Equal-Weight
$350 → $250
May-24-22 Initiated Guggenheim
Neutral
Apr-25-22 Downgrade Jefferies
Buy → Hold
$370 → $280
Apr-07-22 Initiated Stephens
Overweight
$377
Feb-17-22 Upgrade Citigroup
Neutral → Buy
$400
Feb-17-22 Reiterated UBS
Buy
$465 → $420
Feb-17-22 Reiterated Morgan Stanley
Overweight
$465 → $430
Feb-17-22 Reiterated Deutsche Bank
Buy
$409 → $350
Feb-17-22 Reiterated BofA Securities
Buy
$445 → $400
Aug-05-21 Resumed Credit Suisse
Neutral
$385
Dec-16-20 Downgrade Citigroup
Buy → Neutral
$270 → $250
Sep-10-20 Upgrade Jefferies
Hold → Buy
$254
Jul-01-20 Upgrade BofA Securities
Neutral → Buy
$192
Show Previous Ratings
Today 12:47PM
Apr-22-24 08:00AM
Apr-18-24 12:09PM
Apr-16-24 11:50AM
08:00AM
08:00AM
Loading…
Apr-12-24 08:00AM
Apr-11-24 09:10AM
08:00AM
Apr-09-24 08:00AM
Apr-04-24 08:00AM
Apr-01-24 08:00AM
Mar-27-24 08:00AM
Mar-26-24 09:39AM
Mar-23-24 09:00AM
(The Wall Street Journal)
Mar-21-24 08:00AM
11:30AM
Loading…
Mar-15-24 11:30AM
10:30AM
Mar-14-24 09:46AM
08:00AM
Mar-12-24 08:00AM
12:11AM
Mar-07-24 12:27PM
Mar-01-24 11:32PM
Feb-29-24 02:00AM
Feb-26-24 08:41AM
Feb-21-24 10:40AM
08:00AM
Feb-20-24 01:15PM
08:08AM
Feb-15-24 01:00PM
10:54AM
Loading…
10:54AM
12:38AM
Feb-14-24 08:06PM
(Morningstar Research) +11.30%
09:30AM
09:30AM
08:09AM
07:19AM
(Associated Press Finance)
07:00AM
Feb-13-24 08:20AM
Feb-09-24 09:15AM
Feb-01-24 10:08AM
Jan-29-24 08:00AM
Jan-27-24 09:00AM
Jan-24-24 04:30PM
Jan-23-24 04:30PM
Jan-18-24 09:10AM
Jan-16-24 08:00AM
(Investor's Business Daily)
08:00AM
Jan-12-24 02:02PM
09:00AM
Jan-08-24 08:00AM
Jan-02-24 09:00AM
(The Wall Street Journal)
Dec-19-23 08:01AM
Dec-18-23 08:00AM
Dec-13-23 08:29AM
Dec-12-23 08:00AM
Dec-08-23 11:30AM
Dec-07-23 01:53PM
Dec-05-23 07:29AM
Dec-02-23 01:05AM
Nov-29-23 07:57AM
Nov-28-23 08:00AM
Nov-27-23 08:30AM
Nov-22-23 03:04AM
Nov-20-23 08:34PM
Nov-17-23 06:45PM
08:40AM
Nov-16-23 12:59PM
08:00AM
Nov-13-23 09:04AM
Nov-10-23 12:11PM
Nov-09-23 05:14PM
08:00AM
01:33AM
(Thomson Reuters StreetEvents)
Nov-08-23 03:20PM
10:59AM
09:30AM
08:54AM
08:26AM
07:06AM
(Associated Press Finance)
07:00AM
Nov-06-23 10:27AM
Nov-01-23 10:01AM
09:13AM
Oct-25-23 08:06PM
(Morningstar Research) -5.97%
Oct-24-23 12:10PM
Oct-23-23 10:10AM
Oct-19-23 08:00AM
Oct-16-23 08:30AM
08:00AM
Oct-11-23 08:00AM
Oct-10-23 09:10AM
Oct-05-23 12:55PM
Oct-02-23 11:35AM
Sep-27-23 12:04PM
Sep-26-23 08:02AM
08:00AM
Sep-25-23 11:40AM
08:00AM
Sep-21-23 11:36AM
Charles River Laboratories International, Inc. engages in providing products and services to help pharmaceutical and biotechnology companies. It operates through the following segments: Research Models and Services (RMS), Discovery and Safety Assessment (DSA), and Manufacturing Solutions. The RMS segment includes its insourcing solutions business and Charles River accelerator and development lab footprint. The DSA segment offers regulatory-required safety testing of potential new drugs, vaccines, industrial and agricultural chemicals, consumer products, veterinary medicines, and medical devices. The Manufacturing Solutions segment focuses on microbial solutions and biologics solutions. The company was founded by Henry L. Foster in 1947 and is headquartered in Wilmington, MA.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Knell Michael Gunnar CSVP&Chief Accounting Officer Mar 08 '24 Sale 267.52 808 216,156 7,024 Mar 11 04:42 PM Knell Michael Gunnar CSVP&Chief Accounting Officer Mar 04 '24 Sale 261.05 2,750 717,890 7,832 Mar 05 04:54 PM Creamer Victoria L EVP & Chief People Officer Feb 29 '24 Sale 253.70 5,000 1,268,500 13,550 Mar 01 05:37 PM Parisotto Shannon M CEVP, Disc & Safety Assessment Feb 29 '24 Sale 253.45 3,786 959,545 4,792 Mar 04 04:09 PM Barbo William D Corporate Executive VP & CCO Feb 22 '24 Sale 248.50 4,050 1,006,425 22,879 Feb 23 04:57 PM Parisotto Shannon M CEVP, Disc & Safety Assessment Feb 15 '24 Option Exercise 144.67 5,882 850,949 8,478 Feb 20 05:32 PM Parisotto Shannon M CEVP, Disc & Safety Assessment Feb 15 '24 Sale 241.20 5,882 1,418,767 2,596 Feb 20 05:32 PM LaPlume Joseph W EVP, Corp Strategy & Develop Feb 15 '24 Sale 238.93 838 200,223 24,620 Feb 20 05:20 PM FOSTER JAMES C Chairman, President and CEO Jan 29 '24 Option Exercise 144.67 17,436 2,522,466 227,827 Jan 31 04:59 PM Girshick Birgit Corporate Executive VP & COO Jan 10 '24 Option Exercise 215.19 5,916 1,273,064 50,365 Jan 11 04:09 PM Creamer Victoria L EVP & Chief People Officer Dec 14 '23 Option Exercise 136.70 5,526 755,388 22,032 Dec 18 04:07 PM Creamer Victoria L EVP & Chief People Officer Dec 14 '23 Sale 225.00 5,526 1,243,350 16,506 Dec 18 04:07 PM LaPlume Joseph W EVP, Corp Strategy & Develop Nov 30 '23 Sale 197.73 1,850 365,800 23,133 Dec 01 04:10 PM Girshick Birgit Corporate Executive VP & COO Nov 20 '23 Buy 187.82 1,322 248,298 44,449 Nov 21 05:07 PM FOSTER JAMES C Chairman, President and CEO Nov 14 '23 Buy 178.05 5,620 1,000,641 202,643 Nov 15 09:23 AM LaPlume Joseph W EVP, Corp Strategy & Develop Nov 09 '23 Option Exercise 144.67 9,128 1,320,548 34,111 Nov 13 04:12 PM LaPlume Joseph W EVP, Corp Strategy & Develop Nov 09 '23 Sale 173.48 9,128 1,583,522 24,983 Nov 13 04:12 PM WALLMAN RICHARD F Director Aug 24 '23 Buy 198.79 1,000 198,786 1,000 Aug 29 04:23 PM Barbo William D Corporate Executive VP & CCO Aug 10 '23 Option Exercise 144.67 5,511 797,276 9,103 Aug 14 04:17 PM Knell Michael Gunnar CSVP&Chief Accounting Officer Aug 10 '23 Option Exercise 144.67 1,471 212,810 11,411 Aug 14 04:15 PM Barbo William D Corporate Executive VP & CCO Aug 10 '23 Sale 217.24 5,763 1,251,954 3,592 Aug 14 04:17 PM Knell Michael Gunnar CSVP&Chief Accounting Officer Aug 10 '23 Sale 216.54 1,471 318,530 9,940 Aug 14 04:15 PM LaPlume Joseph W EVP, Corp Strategy & Develop Aug 10 '23 Sale 216.52 700 151,564 24,983 Aug 14 04:11 PM LaPlume Joseph W EVP, Corp Strategy & Develop May 15 '23 Sale 190.39 345 65,685 24,026 May 16 02:18 PM LaPlume Joseph W EVP, Corp Strategy & Develop May 12 '23 Sale 193.03 959 185,116 24,371 May 15 02:49 PM MASSARO GEORGE Director May 11 '23 Sale 193.43 288 55,708 4,964 May 15 02:42 PM
Index RUT P/E 29.20 EPS (ttm) 3.20 Insider Own 2.50% Shs Outstand 18.46M Perf Week 2.41%
Market Cap 1.73B Forward P/E 13.86 EPS next Y 6.74 Insider Trans -12.63% Shs Float 18.01M Perf Month -1.43%
Income 62.48M PEG 2.16 EPS next Q 0.89 Inst Own 93.52% Short Float 1.56% Perf Quarter -11.06%
Sales 1.40B P/S 1.23 EPS this Y 15.17% Inst Trans -7.85% Short Ratio 2.37 Perf Half Y -4.63%
Book/sh 28.86 P/B 3.24 EPS next Y 19.18% ROA 5.08% Short Interest 0.28M Perf Year 13.44%
Cash/sh 0.66 P/C 142.04 EPS next 5Y 13.50% ROE 11.52% 52W Range 70.66 - 113.31 Perf YTD -9.11%
Dividend Est. - P/FCF 13.72 EPS past 5Y 38.81% ROI 6.98% 52W High -17.54% Beta 0.59
Dividend TTM - Quick Ratio 1.32 Sales past 5Y 10.46% Gross Margin 28.20% 52W Low 32.24% ATR (14) 1.94
Dividend Ex-Date - Current Ratio 1.32 EPS Y/Y TTM -11.17% Oper. Margin 9.81% RSI (14) 46.46 Volatility 2.35% 1.89%
Employees 6480 Debt/Eq 0.70 Sales Y/Y TTM 20.69% Profit Margin 4.47% Recom 1.00 Target Price 137.67
Option/Short Yes / Yes LT Debt/Eq 0.68 EPS Q/Q -82.76% Payout 0.00% Rel Volume 1.38 Prev Close 92.99
Sales Surprise -0.73% EPS Surprise 13.63% Sales Q/Q 8.97% Earnings Apr 30 AMC Avg Volume 118.32K Price 93.44
SMA20 -0.28% SMA50 -4.16% SMA200 -6.07% Trades
Volume 162,758 Change 0.48%
Date
Action
Analyst
Rating Change
Price Target Change
Dec-18-20 Upgrade The Benchmark Company
Hold → Buy
$64
May-01-20 Downgrade The Benchmark Company
Buy → Hold
Aug-05-19 Reiterated Barrington Research
Outperform
$57 → $68
May-02-19 Reiterated The Benchmark Company
Buy
$56 → $58
Sep-18-18 Reiterated The Benchmark Company
Buy
$52 → $54
Aug-28-18 Upgrade Barrington Research
Mkt Perform → Outperform
$55
Aug-01-18 Upgrade The Benchmark Company
Hold → Buy
$52
Sep-08-17 Upgrade William Blair
Mkt Perform → Outperform
May-23-17 Initiated The Benchmark Company
Hold
Mar-24-17 Upgrade Avondale
Mkt Perform → Mkt Outperform
Feb-21-17 Downgrade Barrington Research
Outperform → Mkt Perform
Aug-01-16 Reiterated Barrington Research
Outperform
$67 → $69
Feb-23-16 Reiterated Deutsche Bank
Buy
$65 → $60
Oct-26-15 Reiterated Barrington Research
Outperform
$82 → $64
Feb-25-15 Reiterated Deutsche Bank
Buy
$80 → $76
Jan-28-15 Reiterated Stifel
Buy
$75 → $80
Apr-30-14 Reiterated Stifel
Buy
$74 → $75
Nov-07-13 Reiterated Deutsche Bank
Buy
$60 → $63
Oct-16-13 Reiterated Deutsche Bank
Buy
$55 → $60
Jun-21-13 Initiated Stifel
Buy
$52
Show Previous Ratings
Apr-18-24 12:00PM
Apr-16-24 09:05AM
Apr-03-24 12:45PM
Mar-28-24 09:55AM
Mar-27-24 09:40AM
12:45PM
Loading…
Mar-18-24 12:45PM
Mar-11-24 05:00PM
Mar-07-24 09:55AM
Mar-06-24 05:01PM
Mar-04-24 09:05AM
Mar-01-24 09:40AM
Feb-29-24 12:45PM
Feb-28-24 10:19AM
08:26AM
(Thomson Reuters StreetEvents)
Feb-27-24 05:42PM
(Associated Press Finance)
04:59PM
Loading…
04:59PM
04:05PM
Feb-13-24 09:05AM
Feb-12-24 11:00AM
Jan-12-24 11:02PM
Jan-11-24 10:00AM
Jan-09-24 11:00AM
Dec-14-23 03:13PM
09:06AM
Dec-05-23 10:00AM
Dec-04-23 12:45PM
08:50AM
Nov-29-23 11:04PM
10:00AM
Nov-27-23 12:00PM
12:45PM
Loading…
Nov-08-23 12:45PM
Nov-06-23 10:42AM
10:00AM
Nov-02-23 06:33PM
05:52PM
(Associated Press Finance)
04:05PM
Oct-31-23 11:54AM
Oct-19-23 09:05AM
Oct-17-23 12:47PM
08:17AM
Oct-06-23 08:50AM
Oct-03-23 11:00AM
Sep-20-23 08:50AM
Sep-19-23 09:00AM
Sep-18-23 10:00AM
Sep-15-23 08:22AM
06:00AM
Sep-08-23 08:23AM
Sep-06-23 09:40AM
07:56AM
Aug-15-23 09:07AM
Aug-14-23 08:08AM
Jul-29-23 10:26AM
Jul-28-23 09:11AM
(Thomson Reuters StreetEvents) +18.11%
Jul-27-23 05:55PM
04:43PM
04:05PM
Jul-13-23 09:05AM
Jun-30-23 05:00AM
Jun-26-23 08:50AM
Jun-20-23 10:00AM
Jun-10-23 08:13AM
Jun-09-23 09:26AM
Jun-08-23 08:50AM
Jun-01-23 09:55AM
09:40AM
May-29-23 11:39AM
May-23-23 08:50AM
May-20-23 10:46AM
May-17-23 10:00AM
May-09-23 08:40AM
May-04-23 12:00PM
May-03-23 10:32AM
(Thomson Reuters StreetEvents) -12.01%
May-02-23 06:05PM
04:05PM
09:15AM
Apr-21-23 08:50AM
06:59AM
Apr-18-23 09:28AM
09:05AM
Apr-14-23 09:15AM
Apr-10-23 09:40AM
Apr-05-23 08:50AM
Mar-29-23 09:40AM
Mar-24-23 09:40AM
Mar-20-23 08:50AM
07:14AM
Mar-07-23 09:40AM
Mar-03-23 08:10PM
Mar-02-23 09:15AM
08:50AM
05:44AM
Mar-01-23 11:55AM
(Thomson Reuters StreetEvents) +16.17%
Feb-28-23 04:05PM
Feb-14-23 09:05AM
Jan-09-23 10:00AM
Dec-28-22 09:40AM
Dec-27-22 02:11PM
09:33AM
Dec-19-22 01:48PM
Huron Consulting Group, Inc. engages in the provision of technology, data, and analytics solutions. It operates through the following segments: Healthcare, Education, and Commercial. The Healthcare segment focuses on serving acute care providers including national and regional health systems, academic health systems, and community health systems, and public, children, and critical access hospitals, and non-acute care providers including physician practices and medical groups, payors, and long-term care or post-acute providers. The Education segment is involved in public and private colleges and universities, research institutes, and other education-related organizations. The Commercial segment includes industries outside of healthcare and education including financial services and energy and utilities. The company was founded in 2002 and is headquartered in Chicago, IL.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Zumwalt Debra Director Apr 02 '24 Sale 94.35 259 24,437 24,703 Apr 04 09:52 AM Singh-Bushell Ekta Director Apr 02 '24 Sale 94.35 192 18,115 12,825 Apr 04 09:55 AM MCCARTNEY JOHN Director Apr 01 '24 Sale 96.38 300 28,914 56,619 Apr 03 11:11 AM Roth James H Director Mar 25 '24 Sale 95.00 6,804 646,380 62,825 Mar 27 11:24 AM Roth James H Director Mar 18 '24 Sale 95.44 6,805 649,452 69,629 Mar 20 10:41 AM Roth James H Director Mar 11 '24 Sale 98.42 6,805 669,779 76,434 Mar 13 09:32 AM Hussey C. Mark CEO and President Mar 08 '24 Sale 100.03 600 60,018 119,094 Mar 11 01:27 PM Hussey C. Mark CEO and President Mar 07 '24 Sale 100.03 2,034 203,461 119,694 Mar 11 01:27 PM Torain Ernest W. Jr. EVP, Gen. Counsel & Corp.Sec. Mar 07 '24 Sale 100.00 650 65,000 15,050 Mar 11 01:29 PM LOCKHART H EUGENE Director Mar 06 '24 Sale 97.95 1,100 107,745 29,997 Mar 08 10:07 AM Roth James H Director Mar 04 '24 Sale 99.28 9,517 944,860 83,239 Mar 06 02:16 PM Hussey C. Mark CEO and President Mar 04 '24 Sale 100.12 1,765 176,712 121,728 Mar 06 02:19 PM MCCARTNEY JOHN Director Mar 01 '24 Sale 98.13 300 29,439 56,919 Mar 05 02:14 PM Hussey C. Mark CEO and President Feb 12 '24 Sale 104.48 4,000 417,910 98,286 Feb 14 10:21 AM Roth James H Director Feb 01 '24 Sale 103.22 2,000 206,440 68,040 Feb 05 09:37 AM MCCARTNEY JOHN Director Feb 01 '24 Sale 103.22 300 30,966 57,219 Feb 05 09:26 AM Hussey C. Mark CEO and President Jan 10 '24 Sale 103.11 4,000 412,440 102,286 Jan 12 10:11 AM Zumwalt Debra Director Jan 03 '24 Sale 101.56 259 26,304 24,962 Jan 05 12:07 PM Singh-Bushell Ekta Director Jan 03 '24 Sale 101.56 192 19,500 13,017 Jan 05 12:09 PM Roth James H Director Jan 02 '24 Sale 101.20 2,000 202,400 70,331 Jan 04 10:53 AM MCCARTNEY JOHN Director Jan 02 '24 Sale 101.20 300 30,360 57,519 Jan 04 10:54 AM Hussey C. Mark CEO and President Dec 11 '23 Sale 104.51 4,000 418,059 106,286 Dec 13 10:52 AM LOCKHART H EUGENE Director Dec 07 '23 Sale 104.00 1,164 121,059 31,097 Dec 11 03:09 PM LOCKHART H EUGENE Director Dec 06 '23 Sale 106.19 62 6,584 32,261 Dec 07 12:14 PM LOCKHART H EUGENE Director Dec 05 '23 Sale 106.24 774 82,230 32,323 Dec 07 12:14 PM Roth James H Director Dec 01 '23 Sale 103.79 2,000 207,580 72,331 Dec 05 11:04 AM MCCARTNEY JOHN Director Dec 01 '23 Sale 103.79 300 31,137 57,819 Dec 05 11:06 AM Singh-Bushell Ekta Director Nov 27 '23 Sale 105.95 5,976 633,138 13,209 Nov 29 11:47 AM MCCARTNEY JOHN Director Nov 06 '23 Sale 101.80 300 30,540 58,119 Nov 08 12:04 PM Roth James H Director Nov 01 '23 Sale 98.37 2,000 196,740 76,331 Nov 03 10:53 AM Zumwalt Debra Director Oct 03 '23 Sale 103.17 259 26,721 25,221 Oct 05 09:29 AM Singh-Bushell Ekta Director Oct 03 '23 Sale 103.17 192 19,809 19,185 Oct 05 09:25 AM Roth James H Director Oct 02 '23 Sale 103.40 2,000 206,800 78,331 Oct 04 10:09 AM Roth James H Director Sep 01 '23 Sale 100.07 2,000 200,140 80,331 Sep 06 11:43 AM Roth James H Director Aug 17 '23 Sale 99.27 2,000 198,540 82,331 Aug 21 11:31 AM LOCKHART H EUGENE Director Aug 14 '23 Sale 99.15 2,100 208,216 33,097 Aug 16 11:01 AM Zumwalt Debra Director Aug 10 '23 Sale 98.15 259 25,421 25,480 Aug 14 09:34 AM Singh-Bushell Ekta Director Aug 08 '23 Sale 100.69 192 19,332 19,377 Aug 10 09:42 AM SAWYER HUGH E III Director Aug 02 '23 Sale 100.78 3,000 302,340 24,833 Aug 04 12:00 PM Featherstone Kyle Chief Acct Officer, Controller Aug 01 '23 Sale 97.55 320 31,216 2,132 Aug 03 11:03 AM Kelly John D. EVP, CFO and Treasurer May 08 '23 Buy 75.29 1,500 112,937 47,798 May 09 10:36 AM Hussey C. Mark CEO and President May 05 '23 Buy 72.48 2,000 144,960 110,286 May 08 10:48 AM
×
Upgrade your FINVIZ experience
Join thousands of traders who make more informed decisions with our premium features.
Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite
